Last update 21 Nov 2024

Sonelokimab

Overview

Basic Info

Drug Type
Nanobody, Trispecific antibody
Synonyms
Anti-IL-17A/F Nanobody, Nanobody, Sonelokinab
+ [5]
Mechanism
IL-17A inhibitors(Interleukin 17A inhibitors), IL-17F inhibitors(Interleukin-17F inhibitors), albumin modulators(Serum albumin modulators)
+ [1]
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, PsoriaticPhase 3-15 Oct 2024
NeoplasmsPhase 3-15 Oct 2024
Hidradenitis SuppurativaPhase 3
CA
14 May 2024
Hidradenitis SuppurativaPhase 3
US
14 May 2024
Chronic large plaque psoriasisPhase 2
BG
31 Jul 2018
Chronic large plaque psoriasisPhase 2
DE
31 Jul 2018
Chronic large plaque psoriasisPhase 2
PL
31 Jul 2018
Axial SpondyloarthritisPhase 2--
PsoriasisPhase 2
CH
-
Pustulosis of Palms and SolesPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
207
(ycqoeviijo) = ooznbcqlrd tntfsbithy (dkilkyuyap )
Positive
10 Mar 2024
Placebo
-
Phase 2
207
(qucqudbhtp) = fwlzhzjdjk yhvjfrttac (qsaldpnhri )
Met
Positive
05 Nov 2023
(qucqudbhtp) = ldelygqtpw yhvjfrttac (qsaldpnhri )
Met
Phase 2
234
Placebo
(baxtxezzrh) = aamardwnoj yqotggmbof (iwqkzjnnrq )
Met
Positive
11 Oct 2023
(baxtxezzrh) = tsqfeavncx yqotggmbof (iwqkzjnnrq )
Met
Phase 2
234
xgyjzyegjn(fjepyppjgz) = rsdpkswvfh njwctmbfvc (sfkhfbzokz )
Positive
11 Oct 2023
xgyjzyegjn(fjepyppjgz) = bjlkagotkr njwctmbfvc (sfkhfbzokz )
Phase 1
41
(MSB0010841 30 mg)
rbeyuaxisg(ljsbevytex) = jjklnnuhih stzqxuwqpk (mmeiltvhlj, qdlkcuieca - esespvppsf)
-
19 Jan 2017
(MSB0010841 60 mg)
rbeyuaxisg(ljsbevytex) = uqtmkjcjpp stzqxuwqpk (mmeiltvhlj, shefngukge - sijdodptcr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free